Sosei Heptares, University of Glasgow, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, University of Glasgow, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, OXGENE Biotechnology, Eli Lilly & Co - Neuroscience Discovery, Eli Lilly & Co - Neuroscience Discovery, Eli Lilly and Company, Ltd - Research and Development, Eli Lilly & Co - Neuroscience Discovery, Institute of Scientific Research and High Technology Services (INDICASAT AIP) - Center for Neuroscience, Institute of Scientific Research and High Technology Services (INDICASAT AIP) - Center for Neuroscience, University of Oxford, Duke-NUS Medical School, University of Oxford - Department of Psychiatry, The University of Manchester, Sosei Heptares, Monash University - Drug Discovery Biology, Protogenia Consulting, Ltd., Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Monash University - Drug Discovery Biology, Monash University - Monash Institute of Pharmaceutical Sciences, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares, Sosei Heptares and University of Glasgow - The Centre for Translational Pharmacology

University of Oslo, University of Oxford - Department of Psychiatry, Ruhr-University Bochum, University of Oslo, University of Oxford - Department of Psychiatry, University of Oslo, COMPASS Pathways Plc, Ruhr-University Bochum, University of Oslo, University of Oslo, University of Oslo, Orkland Municipality, University of Oslo, Norwegian University of Science and Technology (NTNU), University of Oslo - NORMENT and University of Oslo